Pindolol
PINDOLOL TABLETS USP
Approved
Approval ID
e1049edf-376e-317b-e053-2995a90a2aac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 6, 2023
Manufacturers
FDA
Marlex Pharmaceuticals, Inc.
DUNS: 782540215
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Pindolol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10135-744
Application NumberANDA073609
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pindolol
Product Specifications
Route of AdministrationORAL
Effective DateJuly 6, 2023
FDA Product Classification
INGREDIENTS (5)
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
PINDOLOLActive
Quantity: 10 mg in 1 1
Code: BJ4HF6IU1D
Classification: ACTIB
Pindolol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10135-743
Application NumberANDA073609
Product Classification
M
Marketing Category
C73584
G
Generic Name
Pindolol
Product Specifications
Route of AdministrationORAL
Effective DateJuly 6, 2023
FDA Product Classification
INGREDIENTS (5)
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
PINDOLOLActive
Quantity: 5 mg in 1 1
Code: BJ4HF6IU1D
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT